Skip to main content
. Author manuscript; available in PMC: 2018 Jul 1.
Published in final edited form as: Cancer. 2017 Mar 21;123(13):2489–2496. doi: 10.1002/cncr.30620

Table 2.

Three-year time-to-event estimates

Endpoint Number of events
3-year estimate (%) 95% confidence interval (%)
First 3 years Total
Freedom from progression 20 26 73.0 62.9 to 83.1
Local-regional progression 0 0 0.0 Not applicable
Distant metastasis 5 11 6.8 2.5 to 14.0
Biochemical failure 19 25 25.7 16.3 to 36.1
Overall survival 1 3 98.6 96.0 to 100
Prostate cancer death 0 2 0.0 Not applicable
Non-prostate-cancer death 1 1 1.4 0.1 to 6.5